Literature DB >> 3112923

Three stage carcinogenesis in mouse skin--recent results and present status of an advanced model system of chemical carcinogenesis.

E Hecker.   

Abstract

In the three stage model of carcinogenesis in mouse skin, to a certain compartment of normal cells new and adverse biological properties are imposed by the initiator DMBA yielding 'potential tumor cells,' or 'initiated cells.' These initiated cells exhibit a selective advantage of growth over surrounding normal cells if exposed to DTE promoters. The new properties may result from a genomic mutation associated with an increase of density, affinity or cooperativity of certain membrane receptors as compared to normal cells. Complete promoters, such as TPA, but not incomplete promoters such as RPA may impose a second additional genomic or epigenomic insult onto initiated cells ('conversion'). As a consequence, initiated cells become ready to respond to unspecific mitogenic stimuli ('propagation'), as provided by hyperplasiogenic agents. The initiation/promotion model of mouse skin presents new and attractive possibilities to apply the oncogene approach for further in-depth analysis of the molecular mechanisms of its stages. It remains to be seen to what extent molecular events demonstrated causative for the stages in the mouse skin model are applicable also to stages in multistage models of chemical carcinogenesis operational in other target tissues.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3112923     DOI: 10.1177/019262338701500221

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  6 in total

1.  Soluble and insoluble nickel compounds exert a differential inhibitory effect on cell growth through IKKalpha-dependent cyclin D1 down-regulation.

Authors:  Weiming Ouyang; Dongyun Zhang; Jingxia Li; Udit N Verma; Max Costa; Chuanshu Huang
Journal:  J Cell Physiol       Date:  2009-01       Impact factor: 6.384

Review 2.  Hormonal steroids act as tumour promoters by modulating oncogene expression.

Authors:  C E Sekeris
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

Review 3.  Polychlorinated biphenyls (PCBs) as initiating agents in hepatocellular carcinoma.

Authors:  Gabriele Ludewig; Larry W Robertson
Journal:  Cancer Lett       Date:  2012-12-02       Impact factor: 8.679

Review 4.  Equivocal, explicit and emergent actions of PKC isoforms in cancer.

Authors:  Peter J Parker; Sophie J Brown; Veronique Calleja; Probir Chakravarty; Mathias Cobbaut; Mark Linch; Jacqueline J T Marshall; Silvia Martini; Neil Q McDonald; Tanya Soliman; Lisa Watson
Journal:  Nat Rev Cancer       Date:  2020-11-11       Impact factor: 60.716

5.  Cyclooxygenase-2 induction by arsenite through the IKKbeta/NFkappaB pathway exerts an antiapoptotic effect in mouse epidermal Cl41 cells.

Authors:  Weiming Ouyang; Dongyun Zhang; Qian Ma; Jingxia Li; Chuanshu Huang
Journal:  Environ Health Perspect       Date:  2006-12-14       Impact factor: 9.031

6.  PI-3K/Akt pathway-dependent cyclin D1 expression is responsible for arsenite-induced human keratinocyte transformation.

Authors:  Weiming Ouyang; Wenjing Luo; Dongyun Zhang; Jinlong Jian; Qian Ma; Jingxia Li; Xianglin Shi; Jingyuan Chen; Jimin Gao; Chuanshu Huang
Journal:  Environ Health Perspect       Date:  2008-01       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.